Rapid automated analysis using the novel neofleX™ platform
MALDI MS is ideally suited to increase productivity with rapid automated measurements. They provide near instant mass verification and information about impurities and degradants, which is valuable in quality control, assay optimization, and verification of substrates. Learn how the novel neofleX™ MALDI-TOF/TOF system enhances these workflows.
Key Learning Objectives:
- Overview of neofleX™ technology and its benefits to life sciences applications
- Rapid automated analysis of a wide range of analytes including oligonucleotides and peptides
- Software solutions for batch mode post-processing of automated runs
Who Should Attend:
- Characterization team leaders in biopharma companies and CROs
- Mass spectrometry core lab managers
- Anyone who is interested in rapid automated MS analysis
- Researchers who would like to learn about the latest MALDI-TOF/TOF technology
- Anyone who is interested in oligonucleotide and peptide analysis
Presenter: Sergei Dikler, Ph.D. (Senior Market Manager, MALDI Technologies, Bruker Scientific LLC, Billerica, MA, USA)
Sergei Dikler, Ph.D., is a Senior Market Manager focused on promoting MALDI technologies. Dr. Dikler received his Ph.D. degree at Texas A&M University. He is an expert in MALDI application development and high-throughput MS
Presenter: Sinduri Vuppala, Ph.D. (Field Applications Specialist, Bruker Scientific LLC, Billerica, MA, USA)
Sinduri Vuppala, Ph.D., is a Field Applications Specialist for non-imaging MALDI applications at Bruker. Dr. Vuppala received her Ph.D., in Analytical Chemistry at the University of South Florida with focus on method development involving MALDI and CCS technologies.
